The ASCCP Guidelines provide evidence-based recommendations for cervical cancer screening, HPV testing, and management of abnormal results. Explore current algorithms, clinical updates, and …

The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide …

• Allow updates to incorporate new test methods as they are validated, and to adjust for decreasing CIN3+ risks as more patients who received HPV vaccination reach screening age • Colposcopy …

Discuss special populations and considerations for screening outside the typical screening. Apply management strategies for abnormal pap and HPV results by using the ASCCP application. …

Confirm your email to receive complimentary access to the ASCCP Management Guidelines web application. By using the app, you agree to the Terms of Use and Privacy Policy. The app is only to …

Updated US consensus guidelines for management of cervical screening abnormalities are needed to accommodate the 3 available cervical screening strategies: primary human papillomavirus (HPV) …

The ASCCP guidelines help determine the risk of developing cervical intraepithelial neoplasia grade 3 or worse (CIN3+), including CIN3, adenocarcinoma in situ, and invasive cervical cancer, and...

Please ensure that female members know your network OB/GYNs. No referral is required if they choose to access a specialist for these preventive services or if your office does not perform pelvic exams …

Risk-based Management Guidelines for abnormal screening results, including post-colposcopy or post-treatment scenarios. Enduring Guidelines apply this approach to new technologies that emerge and …

The American Society of Colposcopy and Cervical Pathology (ASCCP), has published their enduring consensus guidelines and now recognizes the use of p16/Ki-67 dual-stain biomarkers (CINtec® …